Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Tamsulosin Associated with Interstitial Lung Damage in CYP2D6 Variant Alleles Carriers.

International journal of molecular sciences - 16 Apr 2020

Jessurun Naomi T, Wijnen Petal A, Bast Aalt, van Puijenbroek Eugène P, Bekers Otto, Drent Marjolein

Abstract excerpt

Drugs are serious but underestimated causative agents of interstitial lung disease (ILD). Both cytotoxic and immune mechanisms may be involved in drug-induced ILD (DI-ILD). We aimed to investigate whether polymorphisms of relevant CYP enzymes involved in the metabolization of tamsulosin might explain the pathologic mechanism of the DI-ILD in the cases with suspected tamsulosin DI-ILD. We collected 22...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Aged
Share to Aged, 80 and over
Share to Alleles

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Case-Control Studies

Share to Cytochrome P-450 CYP2D6

Share to Genotype

Share to Lung Diseases, Interstitial

Share to Polymorphism, Single Nucleotide

Source

Open in PubMed Open full text

Identifiers

PMID: 32316326
DOI: 10.3390/ijms21082770
PMCID: PMC7215842

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Tamsulosin Associated with Interstitial Lung Damage in CYP2D6 Variant Alleles Carriers.PMID 32316326Read ↗

Drug-Gene Risk Stratification in Patients with Suspected Drug-Induced Interstitial Lung DiseaseSemantic proximity Read ↗

Cytochrome P450 polymorphisms and drug-induced interstitial lung disease.Semantic proximity Read ↗

Tamsulosin exposure is significantly increased by the CYP2D6*10/*10 genotype.Semantic proximity Read ↗

Role of cytochrome P450 polymorphisms in the development of pulmonary drug toxicity: a case-control study in the Netherlands.Semantic proximity Read ↗

Epigenetic modifications in idiosyncratic drug-induced liver injury: A systematic reviewSemantic proximity Read ↗

Pharmacogenetics and interstitial lung disease.Semantic proximity Read ↗

Antituberculosis Drug-Induced Adverse Events in the Liver, Kidneys, and Blood: Clinical Profiles and Pharmacogenetic Predictors.Semantic proximity Read ↗

Associations of HLA and drug-metabolizing enzyme genes in co-trimoxazole-induced severe cutaneous adverse reactions.Semantic proximity Read ↗

Whole genome sequencing identifies genetic variants associated with co-trimoxazole hypersensitivity in Asians.Semantic proximity Read ↗

Genetic variants associated with immune-mediated liver injury from checkpoint inhibitors.Semantic proximity Read ↗

Significance of genetic polymorphism of CYP2D6 in the pathogenesis of systemic sclerosis.Semantic proximity Read ↗

Association of Drug Metabolic Enzyme Genetic Polymorphisms and Adverse Drug Reactions in Patients Receiving Rifapentine and Isoniazid Therapy for Latent Tuberculosis.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.